Sanofi-aventis' Multaq


This approval follows the European Commission positive opinion issued on September 25, 2009 by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicine agency (EMEA). Multaq

Published on : Mon, 30 Nov 2009


Print as PDF
This approval follows the European Commission positive opinion issued on September 25, 2009 by the Committee for Medicinal Products for Human Use (CHMP) o

No comment


Please login to leave a comment...